Validations: CM Control Strategy & Digital Twins

CM Control Readiness Review: Templates and Gate Criteria

CM Control Readiness Review: Templates and Gate Criteria CM Control Readiness Review: Templates and Gate Criteria Introduction to Continuous Manufacturing and Real-Time Release Testing Continuous manufacturing has emerged as a transformative paradigm in the pharmaceutical industry, allowing for ongoing production and immediate quality assurance through methods such as real-time release testing (RTRT) and process analytical technology (PAT). This transition from…

Continue Reading CM Control Readiness Review: Templates and Gate Criteria

Control Strategy for Blend Uniformity: Real-Time Signals and Actions

Control Strategy for Blend Uniformity: Real-Time Signals and Actions Control Strategy for Blend Uniformity: Real-Time Signals and Actions Continuous manufacturing (CM) is rapidly gaining traction in the pharmaceutical industry, necessitating robust control strategies to ensure blend uniformity and product quality. The integration of process analytical technology (PAT) and real-time release testing (RTRT) into this framework enhances process efficiency and compliance…

Continue Reading Control Strategy for Blend Uniformity: Real-Time Signals and Actions

Throughput Changes in CM: Control Impacts and Re-qualification Triggers

Throughput Changes in CM: Control Impacts and Re-qualification Triggers Throughput Changes in Continuous Manufacturing: Control Impacts and Re-qualification Triggers Continuous Manufacturing (CM) presents a transformative approach for the pharmaceutical industry by enhancing efficiency, flexibility, and a more proactive quality assurance model through methodologies such as Process Analytical Technology (PAT) and Real-Time Release Testing (RTRT). However, changes in throughput can significantly…

Continue Reading Throughput Changes in CM: Control Impacts and Re-qualification Triggers

Control Strategy Storyboard: What FDA Expects During Inspections

Control Strategy Storyboard: What FDA Expects During Inspections Control Strategy Storyboard: What FDA Expects During Inspections Introduction to Control Strategies in Continuous Manufacturing In the pharmaceutical industry, the significance of robust control strategies cannot be overstated. A control strategy is a comprehensive plan encompassing all aspects of a manufacturing process to ensure that the product consistently meets its specifications and…

Continue Reading Control Strategy Storyboard: What FDA Expects During Inspections

Material Property Variability: How to Design Robust Controls

Material Property Variability: How to Design Robust Controls Material Property Variability: How to Design Robust Controls In the realm of pharmaceutical manufacturing, the importance of robust control strategies cannot be understated. As regulatory frameworks evolve, particularly in the context of continuous manufacturing and process analytical technology (PAT), it is essential for industry professionals to understand how to navigate material property…

Continue Reading Material Property Variability: How to Design Robust Controls

Integrating PAT into APC: When to Close the Loop

Integrating PAT into APC: When to Close the Loop Integrating PAT into APC: When to Close the Loop Understanding Process Analytical Technology (PAT) in Continuous Manufacturing Process Analytical Technology (PAT) is a crucial element in the pharmaceutical manufacturing landscape, especially within the domain of continuous manufacturing (CM). Its primary objective is to facilitate real-time monitoring and control of manufacturing processes…

Continue Reading Integrating PAT into APC: When to Close the Loop

Advanced Process Control (APC) in CM: MPC/PID Tuning and Fail-Safe Rules

Advanced Process Control (APC) in CM: MPC/PID Tuning and Fail-Safe Rules Advanced Process Control (APC) in CM: MPC/PID Tuning and Fail-Safe Rules In the rapidly evolving landscape of pharmaceutical manufacturing, Continuous Manufacturing (CM) has emerged as a transformative strategy. This approach, supported by Process Analytical Technology (PAT) and advanced methodologies like Real-Time Release Testing (RTRT), requires rigorous validation steps to…

Continue Reading Advanced Process Control (APC) in CM: MPC/PID Tuning and Fail-Safe Rules

Defining Golden Batch Profiles for Continuous Processes

Defining Golden Batch Profiles for Continuous Processes Defining Golden Batch Profiles for Continuous Processes Introduction to Golden Batch Profiles The concept of Golden Batch Profiles (GBP) plays a crucial role in the realm of continuous manufacturing, particularly in the pharmaceutical industry where stringent compliance with regulatory standards such as FDA, EMA, and MHRA are paramount. A GBP serves as a…

Continue Reading Defining Golden Batch Profiles for Continuous Processes

Alarm Strategy & Interlocks: Preventing Bad Material Propagation

Alarm Strategy & Interlocks: Preventing Bad Material Propagation Alarm Strategy & Interlocks: Preventing Bad Material Propagation Introduction to Continuous Manufacturing and Real-Time Release Testing Continuous manufacturing (CM) represents a paradigm shift in pharmaceutical production, enabling constant flow through manufacturing systems as opposed to traditional batch processing. This evolution invariably leads to the need for enhanced strategies to monitor and control…

Continue Reading Alarm Strategy & Interlocks: Preventing Bad Material Propagation

Edge vs Cloud in CM Control: Latency, Resilience, and Part 11 Hooks

Edge vs Cloud in CM Control: Latency, Resilience, and Part 11 Hooks Continuous manufacturing (CM) has emerged as a transformative approach in the pharmaceutical industry, enhancing efficiency and product quality through innovations like process analytical technology (PAT) and real-time release testing (RTRT). This tutorial aims to provide a comprehensive guide on the comparative analysis of edge and cloud computing solutions…

Continue Reading Edge vs Cloud in CM Control: Latency, Resilience, and Part 11 Hooks